Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck KGaA
MedTech
Guardant Health gets FDA nod to expand test for colon cancer
Guardant Health snagged the FDA green light to use its Guardant360 CDx colon cancer diagnostic along with Braftovi, cetuximab and chemotherapy.
Joseph Keenan
Jan 26, 2026 8:15am
Merck KGaA becomes latest partner for Flagship’s Valo Health
Nov 20, 2025 6:30am
Regeneron, Sanofi receive 1- to 2-month priority review vouchers
Oct 17, 2025 8:30am
As 2 CEOs depart, life sciences face leadership void for women
Oct 3, 2025 11:22am
Merck KGaA picks new pilot for turbulent times—Chutes & Ladders
Sep 26, 2025 8:30am
Merck KGaA lands new R&D chief—Chutes & Ladders
Sep 5, 2025 8:30am
